Healthcare staffing company AMN Healthcare Services (NYSE: AMN) will be announcing earnings results this Thursday after market close. Here’s what to look for.
AMN Healthcare Services beat analysts’ revenue expectations last quarter, reporting revenues of $673.2 million, up 2.3% year on year. It was an incredible quarter for the company, with a beat of analysts’ EPS estimates and revenue guidance for next quarter exceeding analysts’ expectations.
Is AMN Healthcare Services a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting AMN Healthcare Services’s revenue to grow 2.3% year on year, a reversal from the 7.7% decrease it recorded in the same quarter last year.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings. AMN Healthcare Services has a history of exceeding Wall Street’s expectations.
Looking at AMN Healthcare Services’s peers in the healthcare providers & services segment, some have already reported their Q3 results, giving us a hint as to what we can expect. Pediatrix Medical Group delivered year-on-year revenue growth of 1.7%, beating analysts’ expectations by 0.9%, and The Ensign Group reported revenues up 14.5%, falling short of estimates by 7.1%. Pediatrix Medical Group traded up 3.1% following the results while The Ensign Group was also up 8.6%.
Read our full analysis of Pediatrix Medical Group’s results here and The Ensign Group’s results here.
There has been positive sentiment among investors in the healthcare providers & services segment, with share prices up 2.8% on average over the last month. AMN Healthcare Services is up 23% during the same time and is heading into earnings with an average analyst price target of $36.57 (compared to the current share price of $45.32).
WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.
This is what the early days of Palantir looked like before it became a giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.
